Computationally efficient meta-analysis of gene-based tests using summary statistics in large-scale genetic studies
View abstract on PubMed
Summary
This summary is machine-generated.REMETA is a new tool for efficient gene-based meta-analysis in large genetic studies. It simplifies data sharing by using a single reference file, enabling broader collaboration in exome sequencing research.
Area Of Science
- Genetics
- Bioinformatics
- Statistical Genetics
Background
- Meta-analysis of gene-based tests is crucial for genetic association studies.
- Current methods necessitate sharing large covariance matrices, posing challenges for large-scale studies with multiple phenotypes.
Purpose Of The Study
- To introduce REMETA, an efficient tool for gene-based meta-analysis.
- To overcome the data sharing limitations of existing meta-analysis approaches.
Main Methods
- REMETA utilizes a single sparse covariance reference file per study, rescaled for each phenotype using single-variant summary statistics.
- New methods were developed for binary traits with case-control imbalance and for estimating allele frequencies, genotype counts, and effect sizes for burden tests.
Main Results
- Demonstrated REMETA's performance and advantages through a meta-analysis of five traits in 469,376 UK Biobank samples.
- The approach effectively handles large datasets and diverse phenotypes.
Conclusions
- REMETA offers an efficient solution for gene-based meta-analysis, reducing computational and storage burdens.
- The open-source software facilitates meta-analysis across large-scale exome sequencing studies, promoting wider research collaboration.
Related Concept Videos
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...

